Immunogenicity, Safety and Efficacy Comparison of Wockhardt’s Biosimilar Insulin Glargine—Glaritus® with Reference Product— Lantus®: Study Protocol & Early Data Trends (Articles)
S. K. Sharma, A. K. Ajmani, P. Khosla, P. Mukhopadhyay, G. Bhatia, K. G. Prakash, G. Chhaya, P. D. Supe, V. Pavithran, H. Bora, R. Jain, S. Ingole, A. Shah
Open Journal of Endocrine and Metabolic Diseases
Vol.8 No.8,August 30, 2018
DOI:
10.4236/ojemd.2018.88016
550 Downloads 1,008 Views Citations